Monarch Therapeutics

Monarch Therapeutics

PA - Philadelphia
Biotechnology1 H-1B visas (FY2023)

Focus: Adoptive Drug Conjugates

Monarch Therapeutics is a life sciences company focused on Adoptive Drug Conjugates.

Infectious DiseasesOncologyImmunology
Open Jobs
0

Products & Portfolio (1)

24 discontinued products not shown

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts
Portfolio: 25 approved products
Top TAs: Infectious Diseases, Oncology, Immunology
H-1B (2023): 1 approval
Portfolio Health
LOE Approaching12 (48%)
Post-LOE13 (52%)
25 total products
Therapeutic Area Focus
Oncology
2 marketed
Immunology
1 marketed
Marketed
Pipeline

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub